HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

Title
HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
Authors
Keywords
-
Journal
Cancer Immunology Research
Volume 3, Issue 12, Pages 1375-1385
Publisher
American Association for Cancer Research (AACR)
Online
2015-08-22
DOI
10.1158/2326-6066.cir-15-0077-t

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started